A research team led by Dr. Martin Mollenhauer from the Heart Center at University Hospital Cologne has investigated the link ...

Inside cells, two important enzymes act like small central regulatory hubs: dipeptidyl peptidase 8 and 9—DPP8/9 for short.

The positive effects of lanifibranor on liver inflammation and the improved blood lipid levels indicate that a combination of lanifibranor and enzyme replacement therapy for LAL deficiency may ...

In contrast to microbiological enzyme targets ... Along this line, CMTs are the most developed for the treatment of vascular and inflammatory diseases. The short-term use of parenteral MMPIs ...

The incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) has been escalating annually, positioning ...

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...

Objective: To compare the short-term efficacy and tolerability of an oral enzyme therapy with the NSAID diclofenac in patients with symptomatic osteoarthritis of the knee (gonarthritis).

A preclinical study from scientists at Scripps Research finds that a apremilast, a drug already FDA-approved for treating ...

Blocking this enzyme helps keep inflammation in check ... If future trials confirm these benefits in humans, this treatment might not just slow the disease—it could change the way it develops ...

or a compound that blocks an enzyme involved in inflammation—could be repurposed as a dual-acting therapy for AUD, particularly in individuals who have pain during and after alcohol use.

A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity-two issues ...